Published in Med J Aust on February 21, 2005
Safety, Tolerability, and Compliance with Long-Term Antimalarial Chemoprophylaxis in American Soldiers in Afghanistan. Am J Trop Med Hyg (2015) 0.89
Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment. Eur J Clin Pharmacol (2007) 0.83
Malaria chemoprophylaxis: in war and peace. Med J Aust (2005) 0.79
Rational Risk-Benefit Decision-Making in the Setting of Military Mefloquine Policy. J Parasitol Res (2015) 0.78
Tetracyclines in malaria. Malar J (2015) 0.77
Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force. J Parasitol Res (2015) 0.75
A small-fish model for behavioral-toxicological screening of new antimalarial drugs: a comparison between erythro- and threo-mefloquine. BMC Res Notes (2015) 0.75
Neuropsychiatric Outcomes After Mefloquine Exposure Among U.S. Military Service Members. Am J Trop Med Hyg (2016) 0.75
Modern malaria chemoprophylaxis. Drugs (2005) 3.40
Artemisone--a highly active antimalarial drug of the artemisinin class. Angew Chem Int Ed Engl (2006) 2.09
Plasmodium vivax trophozoites insensitive to chloroquine. Malar J (2008) 1.54
Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects. Am J Trop Med Hyg (2008) 1.47
Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. J Infect Dis (2004) 1.22
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother (2009) 1.21
Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam. Antimicrob Agents Chemother (2009) 1.14
Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam. Trop Med Int Health (2009) 1.08
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone. Antimicrob Agents Chemother (2008) 1.07
Malaria vectors of Timor-Leste. Malar J (2010) 1.03
Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects. Antimicrob Agents Chemother (2008) 1.02
Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects. Am J Trop Med Hyg (2009) 1.00
Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor. Am J Trop Med Hyg (2006) 0.99
Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects? Br J Clin Pharmacol (2006) 0.94
Lack of sex effect on the pharmacokinetics of primaquine. Am J Trop Med Hyg (2006) 0.94
Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine. Trans R Soc Trop Med Hyg (2007) 0.92
Tafenoquine for the treatment of recurrent Plasmodium vivax malaria. Am J Trop Med Hyg (2007) 0.92
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis. Malar J (2015) 0.91
Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum. Antimicrob Agents Chemother (2009) 0.90
Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp. J Med Chem (2012) 0.85
Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold. Org Biomol Chem (2015) 0.85
Survey of personal protection measures against mosquitoes among Australian defense force personnel deployed to East Timor. Mil Med (2003) 0.85
Short report: Molecular evaluation of the efficacy of chloroquine treatment of uncomplicated Plasmodium falciparum malaria in East Timor. Am J Trop Med Hyg (2002) 0.84
Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects. Antimicrob Agents Chemother (2007) 0.82
Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers. Antimicrob Agents Chemother (2011) 0.79
Evaluation of the safety and tolerability of a short higher-dose primaquine regimen for presumptive anti-relapse therapy in healthy subjects. Trans R Soc Trop Med Hyg (2011) 0.78
Efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum infection in East Timor, 2000. Acta Trop (2003) 0.77
Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxopurine phosphoribosyltransferases and have antimalarial activity. J Med Chem (2013) 0.77
Comparison of self-reported and audiometrically-measured hearing loss in the Australian Defence Force. Int J Audiol (2011) 0.76
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria. J Pharm Pharmacol (2012) 0.76
Fatty food does not alter blood mefloquine concentrations in the treatment of falciparum malaria. Trans R Soc Trop Med Hyg (2005) 0.75
Phenolic glycosides with antimalarial activity from Grevillea "Poorinda Queen". J Nat Prod (2010) 0.75
Protection of Military Personnel Against Vector-Borne Diseases: A Review of Collaborative Work of the Australian and US Military Over the Last 30 Years. US Army Med Dep J (2016) 0.75
Self-reported tinnitus and ototoxic exposures among deployed Australian Defence Force personnel. Mil Med (2011) 0.75